258516-84-6

Basic information

• Product Name: Dibenzyl chloroMethyl phosphate
• Synonyms: Phosphoric acid, chloromethyl bis(phenylmethyl) ester
• CAS NO: 258516-84-6
• Molecular Formula: C₁₅H₁₆ClO₄P
• Molecular Weight: 326.711901
• Product Categories: Primary Amines;Analytical Reagents;Analytical/Chromatography;Building Blocks;by Application;Chemical Synthesis;Derivatization Reagents;Derivatization Reagents HPLC;HPLC Derivatization Reagents;Organic Building Blocks;Phosphorus Compounds;Phosphorus Halides;UV-VIS
• Mol File: 258516-84-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: ?20°C
• CAS DataBase Reference: Dibenzyl chloroMethyl phosphate(CAS DataBase Reference)
• NIST Chemistry Reference: Dibenzyl chloroMethyl phosphate(258516-84-6)
• EPA Substance Registry System: Dibenzyl chloroMethyl phosphate(258516-84-6)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• Hazardous Substances Data: 258516-84-6(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 258516-84-6 differently. You can refer to the following data:
1. Synthesis of water-soluble prodrugs of lipophilic alcohols, phenols and amines. Dibenzyl chloromethyl phosphate is an improved derivative of the well known Di-tert-butyl chloromethyl phosphate. So it can be detected more easily by HPLC-UV, because of higher stability, higher yields and better UV-activity.
2. Dibenzyl (Chloromethyl) Phosphate acts as a reagent in the screening and synthesis of potent NPP6 inhibitor.

Upstream product

• 49715-04-0 chlorosulfuric acid chloromethyl ester 
• 97174-13-5 sodium dibenzyl phosphate 
• 50651-75-7 silver dibenzylphosphate 
• 593-71-5 Chloroiodomethane 
• 3518-65-8 monochloromethanesulfonyl chloride 
• 1623-08-1 phosphoric acid dibenzyl ester 

Downstream Products

• 1004980-19-1 C₃₅H₃₄ClN₂O₈P 
• 1253913-11-9 C₃₆H₃₁O₈P 
• 1365438-35-2 (S)-benzyl((dimethyl(3-(naphthalen-1-yloxy)-1-phenylpropyl)ammonio)methyl)phosphate 
• 1443300-51-3 ethyl 3-(benzyloxy)-4-(((bis(benzyloxy)phosphoryl)oxy)methoxy)-5-(dimethylcarbamoyl)-1-(4-methoxyphenyl)-1H-pyrrole-2-carboxylate 
• 1443300-66-0 ethyl 4-(benzyloxy)-3-(((bis(benzyloxy)phosphoryl)oxy)methoxy)-5-(dimethylcarbamoyl)-1-(4-methoxyphenyl)-1H-pyrrole-2-carboxylate 
• 1486547-68-5 ursodeoxycholic acid (bis(benzyloxy)phosphoryloxy)methyl ester 
• 1609978-85-9 {[bis(benzyloxy)phosphoryl]oxy}methyl trans-4-[(1R)-1-(6-{[4-(difluoromethyl)pyridin-2-yl]amino}-4-methyl-2,3'-bipyridin-6'-yl)-1-hydroxyethyl]cyclohexanecarboxylate 

Relevant articles and documents

Conjugate of cytotoxin molecule and cell binding receptor molecule

A conjugate of a strong cytotoxin molecule and a cell binding receptor molecule has a structure shown in a molecular formula (I), wherein T, L, m, n, -----, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are defined in the text. The conjugate is used for treating cancer, immunological diseases and infectious diseases.

METHODS OF BLADDER CANCER TREATMENT WITH CICLOPIROX, CICLOPIROX OLAMINE, OR A CICLOPIROX PRODRUG

A method of treating bladder cancer is provided. The method of treating bladder cancer can include: providing a pharmaceutical composition having ciclopirox or ciclopirox olamine or a ciclopirox-POM prodrug having a structure of one of the formulae provided herein or derivative thereof or stereoisomer thereof or pharmaceutically acceptable salt thereof; and administering the pharmaceutical composition to a subject having the bladder cancer. The ciclopirox or ciclopirox olamine or a ciclopirox-POM prodrug can be administered in a therapeutically effective amount.

PHENOL DERIVATIVE AND PREPARATION METHOD AND USE IN MEDICINE THEREOF

The present invention relates to a phenol derivative and the preparation method and use in medicine thereof, and particular to a phenol derivative represented by general formula (A) or a stereoisomer, a solvate, a metabolite, a prodrug, a pharmaceutically